Authors


Christine K. Norton, MA

Latest:

It Is Time to Ask Patients What Outcomes Are Important to Them

Patients with abdominal or back pain identified 21 outcomes important to them, but the reported outcomes are quite different from the symptom and function outcomes studied by researchers.


Vijay R. Nadipelli, MS, BPharm

Latest:

Heterogeneity of Nonadherent Buprenorphine Patients: Subgroup Characteristics and Outcomes

Patient and treatment heterogeneity were characterized within a sample of nonadherent buprenorphine members; an improved understanding of these factors may optimize patient—treatment matching and intervention efforts.




Peter Sauter, MBA

Latest:

Frequency of and Harm Associated With Primary Care Safety Incidents

Physicians' and nurses' assessments of the frequency and harm of incidents can be a supplemental method to study patient safety in the primary care office.



Thomas P. Harkins, MA, MPH

Latest:

Impact of Certified CME in Atrial Fibrillation on Administrative Claims

Use of administrative claims data is an innovative way of measuring the effect of continuing medical education on physician practice behavior and patient outcomes.


Michal Shani, MD

Latest:

Low Clinical Utility of Folate Determinations in Primary Care Setting

It seems that folate determinations in patients without known risk factors for folate deficiency are of little clinical significance.


Jennifer K. Maratt, MD

Latest:

Colorectal Cancer Screening in the 21st Century: Where Do We Go From Here?

Improving the appropriate use of colorectal cancer screening requires novel approaches to strike a balance between underuse and overuse.



Andrea Klemes, DO

Latest:

Payer Effects of Personalized Preventive Care for Patients With Diabetes

We examine the effects of MD–Value in Prevention (MDVIP) enrollment on Medicare expenditures and utilization among fee-for-service beneficiaries with diabetes over a 5-year period.


Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD

Latest:

The Curse of Being First: Lessons From Pharma’s Blockbuster Drugs

What can we learn from Biogen's decision to halt sales of aducanumab?



Karina L. Berenson, MPH

Latest:

Cost-Offset Analysis: Bimatoprost Versus Other Prostaglandin Analogues in Open-Angle Glaucoma

Treatment of glaucoma with bimatoprost is associated with cost savings compared with treatment with latanoprost or travoprost because of greater intraocular pressure reduction.


Harper Gordek, MPH

Latest:

Risk Adjustment in Home Health Care CAHPS

The authors disagree with previous research concluding that the Home Health Care Consumer Assessment of Healthcare Providers and Services (CAHPS) publicly reported data are insufficiently adjusted for patient comorbidities.



Anke-Peggy Holtorf, PhD, MBA

Latest:

Systematic Analysis of Outcomes Evaluations Applied to Drug Management Programs

Adopting quality measurement standards for drug management programs might increase the effectiveness and long-term sustainability of positive health outcomes for patients.



Gordon Schectman, MD

Latest:

Early Changes in VA Medical Home Components and Utilization

Significant changes were found in patients' utilization of healthcare related to early implementation of medical home components in VA primary care clinics.


Jason Shafrin, PhD

Latest:

The Cost of Adherence Mismeasurement in Serious Mental Illness: A Claims-Based Analysis

This study demonstrates that common pharmacy claims-based measures underestimate the effect of actual adherence on inpatient costs among patients with serious mental illness.


Jeff M. Slezak, MS

Latest:

Preventive Care and Health Behaviors Among Overweight/Obese Men in HMOs

Healthcare organizations may reduce weight-related health risks and disparities in care among overweight/obese patients through promoting cancer screening exams, healthier diets, and physical activity.


K. John McConnell, PhD

Latest:

Variation in Network Adequacy Standards in Medicaid Managed Care

Medicaid managed care network adequacy standards exhibit significant heterogeneity across regions and specialties, potentially creating large variations in health care access and quality.


Jesse C. Crosson, PhD

Latest:

Medical Costs Associated With Type 2 Diabetes Complications and Comorbidities

A large proportion of medical costs for type 2 diabetes are attributable to complications and comorbidities, especially end stage renal disease with dialysis or kidney transplantation.



Evette J. Ludman, PhD

Latest:

Population Targeting and Durability of Multimorbidity Collaborative Care Management

Benefits of a patient-centered multimorbidity care management program occurred early, and were evident only among patients with depression and unfavorable medical control of diabetes and heart disease.



Debra P. Ritzwoller, PhD

Latest:

Effectiveness and Cost of Influenza Vaccine Reminders for Adults With Asthma or Chronic Obstructive Pulmonary Disease

Interactive voice response reminders had neither a positive nor a negative effect on promoting influenza vaccination over reminders via postcards, but are a potentially less expensive option.


Eberechukwu Onukwugha, PhD

Latest:

Binary Measures for Associating Medication Adherence and Healthcare Spending

The use of an 80% threshold or other binary cut point may be insufficient for characterizing the relationship between medication adherence and Medicare spending.



AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo